Investors

Shaping together the future
of medical imaging

Thanks to the continued support of its investors,
Intrasense has expanded its portfolio and
business activities to address new markets
in France and worldwide.

We are ambitious. We are passionate.
We believe in the future through innovation.

News & strategies

Let us share
our strategic directions.

We have identified major opportunities opening up for new applications of Myrian® innovative technologies in the fields of health information systems, artificial intelligence and deep-learning.

Let’s share our road map >

Read our latest news >

Receive "live" our news >

Agenda

> 21/11/15 - Investir Day event - Paris
> 21/09/22 - HALF-YEAR RESULTS WEBINAR - SUBSCRIPTION
> 21/09/22 - Half-year results publication
> 21/03/23 - Yearly results publication
> 20/06/24 - GENERAL MEETING (FRENCH)
> 20/06/03 - Shareholder webinar
> 20/05/20 - Letter to shareholders
> 20/05/18 - Publication of the meeting notice
 
 

Stock market data

Identification

Name: Intrasense
Ticker symbol : ALINS
ISIN code : FR0011179886
Bloomberg : ALINS:FP
Reuters : ALINS.PA
Number of shares : 23.378.925

Capital distribution

Analyst coverage

AURGALYS - Jean-Pierre Loza (18/10/03)
Download the document
AURGALYS - Galina Sotnikova (18/05/23)
Download the document
AURGALYS - Galina Sotnikova (18/05/02)
Download the document
AURGALYS - Galina Sotnikova (18/03/22)
Download the document
AURGALYS - Mickael Dubourd (17/02/15)
Download the document

Investors contact

Intrasense

Investor Relations Department
1231 avenue du Mondial 98
34000 MONTPELLIER | FRANCE
Email : investor@intrasense.fr

Newcap

Roxane Gbedigro & Pierre Laurent
Financial communications
and investor relations
Tel : +33 (0)1 44 71 94 96
Email : intrasense@newcap.eu

Intrasense_blanc

map_20161028

Headquarters / Siège social :
1231, avenue du Mondial 98
34000 MONTPELLIER | FRANCE